# Cipla, Ltd. · 66-66 · INDIA — FDA import alert red lists: firms subject to detention without physical examination

For Cipla, Ltd. · 66-66 · INDIA, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is INDIA; product is Finasteride API; product code is 64 U C S 06 Finasteride (Inhibitor (Decarboxylase)), Human - Rx/Single Ingredient, Active Pharm Ingred/Chems for Further Manuf; date published is 10/18/2010; address is Plots D-7, D-22, D-27 , M.I.D.C. Industrial Area, Taluka-Daund , Kurkumbh Village, Dist. Pune, Maharashtra INDIA, verified against its source on 2026-09-16.

- **Firm:** Cipla, Ltd. _(verified: appears in the quote below)_
- **Import alert:** 66-66
- **Import alert name:** "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- **Country:** INDIA _(verified: appears in the quote below)_
- **Address:** Plots D-7, D-22, D-27 , M.I.D.C. Industrial Area, Taluka-Daund , Kurkumbh Village, Dist. Pune, Maharashtra INDIA _(verified: appears in the quote below)_
- **Date published:** 10/18/2010 _(verified: appears in the quote below)_
- **Product code:** 64 U C S 06 Finasteride (Inhibitor (Decarboxylase)), Human - Rx/Single Ingredient, Active Pharm Ingred/Chems for Further Manuf _(verified: appears in the quote below)_
- **Product:** Finasteride API _(verified: appears in the quote below)_

## What the source says

> Cipla, Ltd. Date Published : 10/18/2010 Plots D-7, D-22, D-27 , M.I.D.C. Industrial Area, Taluka-Daund , Kurkumbh Village, Dist. Pune, Maharashtra INDIA 64 U C S 06 Finasteride (Inhibitor (Decarboxylase)), Human - Rx/Single Ingredient, Active Pharm Ingred/Chems for Further Manuf Date Published: 10/18/2010 Desc: Finasteride API

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_202.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).